Novartis yanks pre-pandemic vaccine application

Faced with a looming deadline to provide more data on the pre-pandemic vaccine Aflunov, Novartis Vaccines and Diagnostics has pulled its application for centralized marketing authorization from the

Australia approves a new bird flu vaccine

Australian officials have approved a bid flu vaccine developed by CSL. And the government announced a $160 million budget to stockpile additional vaccines to help protect the country from an

UK health officials in cancer vaccine fight

When British health officials weighed the benefits of the two cervical cancer vaccines, they concluded that Cervarix from GlaxoSmithKline provided the best value for the money. And that decision

Human trial for Cuban cancer vaccine; Experts question HIV vaccine trial;

Vaccine Research Brazilian scientists say they are preparing to launch clinical trials of an esophagus cancer vaccine developed in Cuba.

Celldex inks tech deal to advance cancer vaccines

Celldex Therapeutics has struck a deal to use 3M's toll-like receptor (TLR) agonist compounds--useful as vaccine adjuvants--for a slate of new oncology vaccines in development. 3M Drug Delivery

Glaxo touts effectiveness of pediatric vaccine candidate

GlaxoSmithKline is touting new, late-stage data that demonstrates how its experimental pediatric vaccine Synflorix effectively protects children from pneumococcal disease. Glaxo filed Synflorix for

Iomai reports success with traveler’s diarrhea patch

Iomai has racked up more positive data for its vaccine patch to prevent traveler's diarrhea. A new study details that only three of 59 volunteers who used the patch experienced a severe or moderate

Cell-based pandemic vaccine successful in human trial

Baxter International says that a human trial of its Celvapan bird flu vaccine demonstrated that it spurred an immune response against three strains of the lethal virus. This is the first time that

Novartis plans trials for growing vaccines pipeline

Novartis is taking the wraps off its vaccine pipeline, highlighting plans for new trials as it talks up a lineup of vaccine candidates. Researchers for the company detailed plans that include a

Vaccine research heads to outer space

A program to develop a new salmonella vaccine has headed to the outer limits. The space shuttle Discovery is carrying a test strain of salmonella, and officials at Spacehab are using the experiment

Planned AIDS vaccine trial raises concerns

The AIDS Vaccine Research Subcommittee of the NIH has OK'd a new AIDS vaccine trial, prompting some skeptics to caution against plunging back into trials so soon after a

Mymetics outlines malaria vaccine approval timeline

Switzerland's Mymetics says that its experimental malaria vaccine could be ready for marketing as early as 2014. CEO Christain Rochet says that clinical trials on the vaccine--obtained from

SPOTLIGHT: Brain cancer vaccine doubles survival time

An experimental brain cancer vaccine more than doubled the survival time of patients suffering from glioblastoma multiforme. Early-stage data demonstrated that patients lived almost three years

ALSO NOTED: Transgene looks for vaccine partner; Shortage of rabies vaccine develops; and much more...

Vaccine Research France's Transgene says it plans to look for a partner to develop its investigational lung cancer vaccine after concluding a successful Phase IIb trial.

New vaccine/chemo combo effective in cancer study

New trial data shows that the combination of a chemotherapy drug and a new vaccine significantly prolonged the survival of patients with glioblastoma, the aggressive brain cancer that now afflicts

Type 1 diabetes vaccine goes into human studies

Researchers have begun human studies of a new vaccine that is designed to block or reverse type 1 diabetes. A team at Children's Hospital in Pittsburgh is loading microspheres with nucleic acid. In

Emergent buys Protein Sciences in $75M deal

Emergent BioSolutions has inked a deal to buy 25-year-old Protein Sciences for $75 million or more. Protein Sciences has been developing a new flu vaccine, FluBlok, relying on a new method that grows

Bavarian Nordic launches early trial for HIV vaccine

Denmark's Bavarian Nordic has launched a Phase I/II trial of an experimental HIV vaccine. Safety data from the study is expected by the end of this year with immunogenicity data following in the

SPOTLIGHT: Analyst lengthens timeline for Cervarix

A Morgan Stanley analyst is raising the prospect that GlaxoSmithKline's Cervarix could be delayed five years beyond the 2009 approval expected by most analysts on Wall Street.

ALSO NOTED: Progress on cancer vaccine; Big shoe maker adds vaccines; and much more...

Vaccine Research A team of researchers say that a human protein could play a key role in developing a new cancer vaccine.